| Name | Rinucumab |
|---|
| Description | Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |